Catheter-directed foam sclerotherapy of axial saphenous reflux: early results

TY - JOUR

T1 - Catheter-directed foam sclerotherapy of axial saphenous reflux: early results

AU - Kölbel, T

AU - Hinchliffe, R J

AU - Lindblad, B

PY - 2007

Y1 - 2007

N2 - OBJECTIVES: Foam sclerotherapy of the great saphenous vein is a relatively new and promising treatment option for patients with axial reflux. Its usefulness may be limited by low primary occlusion rates. We present a standard technique for catheter-directed foam sclerotherapy, which facilitates foam delivery precisely to its intended site of action and potentially improves occlusion rates.METHODS: A consecutive series of 53 patients were treated with foam sclerotherapy using a standard technique for foam delivery at Malmö University Hospital between September 2006 and April 2007. Patients were treated with 3% polidocanol foam through an introducer sheath, which was inserted percutaneously over a guidewire in the great saphenous vein (GSV). All successfully treated patients were examined by colour duplex one week after the procedure.RESULTS: Primary technical success with delivery of foam along the length of the GSV was achieved in 50 of 53 limbs (94%). All treated GSVs were occluded at one week duplex.CONCLUSION: The use of an endovascular sheath inserted percutaneously over a guidewire under duplex ultrasound control is feasible in most patients and has resulted in high primary occlusion rates.

AB - OBJECTIVES: Foam sclerotherapy of the great saphenous vein is a relatively new and promising treatment option for patients with axial reflux. Its usefulness may be limited by low primary occlusion rates. We present a standard technique for catheter-directed foam sclerotherapy, which facilitates foam delivery precisely to its intended site of action and potentially improves occlusion rates.METHODS: A consecutive series of 53 patients were treated with foam sclerotherapy using a standard technique for foam delivery at Malmö University Hospital between September 2006 and April 2007. Patients were treated with 3% polidocanol foam through an introducer sheath, which was inserted percutaneously over a guidewire in the great saphenous vein (GSV). All successfully treated patients were examined by colour duplex one week after the procedure.RESULTS: Primary technical success with delivery of foam along the length of the GSV was achieved in 50 of 53 limbs (94%). All treated GSVs were occluded at one week duplex.CONCLUSION: The use of an endovascular sheath inserted percutaneously over a guidewire under duplex ultrasound control is feasible in most patients and has resulted in high primary occlusion rates.

KW - Catheterization

KW - Feasibility Studies

KW - Humans

KW - Polidocanol

KW - Polyethylene Glycols/administration & dosage

KW - Saphenous Vein/diagnostic imaging

KW - Sclerosing Solutions/administration & dosage

KW - Sclerotherapy/adverse effects

KW - Time Factors

KW - Treatment Outcome

KW - Ultrasonography, Doppler, Color

KW - Ultrasonography, Doppler, Duplex

KW - Ultrasonography, Interventional

KW - Varicose Veins/diagnostic imaging

KW - Venous Insufficiency/diagnostic imaging

U2 - 10.1258/026835507782101681

DO - 10.1258/026835507782101681

M3 - SCORING: Journal article

C2 - 18269073

VL - 22

SP - 219

EP - 222

JO - PHLEBOLOGY

JF - PHLEBOLOGY

SN - 0268-3555

IS - 5

ER -